Results 101 to 110 of about 234 (145)
Is periodontal health a predictor of drug-induced gingival overgrowth? A cross-sectional study
Dental Research Journal, 2014 Background: Gingival overgrowth is a common side-effect of amlodipine regimen on the oral cavity. There is controversy regarding the cause and effect relationship of periodontal health and drug induced gingival overgrowth.
Ruchi Banthia +5 more
doaj
Fixed‐Dose Combinations for Hypertension: Barriers to Use and Opportunities for Health Systems
The Journal of Clinical Hypertension, Volume 28, Issue 6, June 2026.ABSTRACT Background: Uncontrolled hypertension is a leading driver of heart disease, chronic kidney disease, heart failure, dementia, stroke, and pregnancy‐related complications. Fixed‐dose combinations (FDCs) are guideline‐endorsed first‐line therapies that improve blood pressure control by reducing pill burden, improving adherence, and targeting ...
Pranay Narang +4 more
wiley +1 more source
The Determinants of Negotiated Pharmaceutical Prices
The Journal of Industrial Economics, Volume 74, Issue 2, Page 234-260, June 2026.ABSTRACT We focus on the determinants of pharmaceutical drug prices. Using data from the Brazilian pharmaceutical market, we find large variations in drug prices across buyers, drug classes, and time periods. Our estimation results provide evidence that transaction‐specific determinants between buyers and sellers (e.g., transaction volume, buyer's ...
Ralph B. Siebert +2 more
wiley +1 more source
S-amlodipine-induced gingival enlargement
Indian Journal of Nephrology, 2015 openaire +2 more sources
Drug Design, Development and Therapy, 2017 Thomas J Dennison,1 Julian C Smith,2 Raj K Badhan,1 Afzal R Mohammed1 1Aston School of Pharmacy, Aston University, Birmingham, 2Viridian Pharma Ltd, Newport, UK Abstract: Cardiovascular disease (CVD) is the leading cause of death among men and women ...
Dennison TJ +3 more
doaj
Bioequivalence study of S-amlodipine Gentisate Conventional Versus new Formulation [PDF]
Journal of Korean Society for Clinical Pharmacology and Therapeutics, 2008 Yun Jung Choi +5 more
openaire +1 more source
Cutaneous reactions due to antihypertensive drugs
Indian Journal of Dermatology, 2006 Out of a total of 1147 patients on antihypertensive drugs, 23 (2.04%) developed adverse cutaneous drug reactions (ACDR). The commonest antihypertensive drug group causing ACDR was beta-blockers of which atenolol was the commonest culprit.
Upadhayai J +5 more
doaj
Drug Design, Development and TherapyMohammad AY Alqudah,1,2 Mahmoud M Yaseen,3 Karem H Alzoubi,1,2 Belal A Al-Husein,2 Sanaa K Bardaweel,4 Ahmad Y Abuhelwa,1 Ahlam M Semreen,5 Ruba A Zenati,5 Raafat El-Awady,1,5 Mohd Shara,1 Yasser Bustanji,5– 7 Nelson C Soares,8– 10 Eman Abu-Gharbieh,5– 7
Alqudah MAY +14 more
doaj
The Bulletin of Contemporary Clinical Medicine, 2009 Ildus A. Latfoullin +2 more
openaire +1 more source